Viral Vector & Plasmid DNA Manufacturing Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
       1.1.1. Definition of Viral Vector & Plasmid DNA Manufacturing
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Viral Vector & Plasmid DNA Manufacturing Market By Type
                 1.2.2.1. Global Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By Type (2015-2026)
                 1.2.2.2. Global Viral Vector & Plasmid DNA Manufacturing Market Revenue Share By Type in 2017
                 1.2.2.3. Lentivirus
                 1.2.2.4. Adenovirus
                 1.2.2.5. Plasmid DNA
                 1.2.2.6. Adeno-Associated Virus
                 1.2.2.7. Others
       1.2.3. Viral Vector & Plasmid DNA Manufacturing Market By Application
                 1.2.3.1. Global Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By Application (2015-2026)
                 1.2.3.2. Global Viral Vector & Plasmid DNA Manufacturing Market Revenue Share By Application in 2017
                 1.2.3.3. Gene Therapy
                 1.2.3.4. Vaccinology
       1.2.4. Viral Vector & Plasmid DNA Manufacturing Market By Disease
                 1.2.4.1. Global Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By Disease (2015-2026)
                 1.2.4.2. Global Viral Vector & Plasmid DNA Manufacturing Market Revenue Share By Disease in 2017
                 1.2.4.3. Infectious Disease
                 1.2.4.4. Genetic Disorders
                 1.2.4.5. Cancer
                 1.2.4.6. Others
       1.2.5. Viral Vector & Plasmid DNA Manufacturing Market By End Use
                 1.2.5.1. Global Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By End Use (2015-2026)
                 1.2.5.2. Global Viral Vector & Plasmid DNA Manufacturing Market Revenue Share By End Use in 2017
                 1.2.5.3. Research Institutes
                 1.2.5.4. Biotech Companies
                 1.2.5.5. Others
       1.2.6. Viral Vector & Plasmid DNA Manufacturing Market by Geography
                 1.2.6.1. Global Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.6.2. North America Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate (2015-2026)
                 1.2.6.3. Europe Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate (2015-2026)
                 1.2.6.4. Asia-Pacific Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate (2015-2026)
                 1.2.6.5. Latin America Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate (2015-2026)
                 1.2.6.6. Middle East and Africa (MEA) Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Viral Vector & Plasmid DNA Manufacturing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Viral Vector & Plasmid DNA Manufacturing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Viral Vector & Plasmid DNA Manufacturing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Viral Vector & Plasmid DNA Manufacturing Major Manufacturers in 2017

CHAPTER 4. Viral Vector & Plasmid DNA Manufacturing Market By Type

4.1. Global Viral Vector & Plasmid DNA Manufacturing Revenue By Type
4.2. Lentivirus
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Adenovirus
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Plasmid DNA
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Adeno-Associated Virus
       4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
       4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. Viral Vector & Plasmid DNA Manufacturing Market By Application

5.1. Global Viral Vector & Plasmid DNA Manufacturing Revenue By Application
5.2. Gene Therapy
       5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Vaccinology
       5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
       5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. Viral Vector & Plasmid DNA Manufacturing Market By Disease

6.1. Global Viral Vector & Plasmid DNA Manufacturing Revenue By Disease
6.2. Infectious Disease
       6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Genetic Disorders
       6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Cancer
       6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
       6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. Viral Vector & Plasmid DNA Manufacturing Market By End Use

7.1. Global Viral Vector & Plasmid DNA Manufacturing Revenue By End Use
7.2. Research Institutes
       7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Biotech Companies
       7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Others
       7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. North America Viral Vector & Plasmid DNA Manufacturing Market By Country

8.1. North America Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America Viral Vector & Plasmid DNA Manufacturing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
       8.3.1. U.S. Viral Vector & Plasmid DNA Manufacturing Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.4. Canada
       8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.5. Mexico
       8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 9. Europe Viral Vector & Plasmid DNA Manufacturing Market By Country

9.1. Europe Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe Viral Vector & Plasmid DNA Manufacturing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
       9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.4. Germany
       9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.5. France
       9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.6. Spain
       9.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
       9.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.7. Rest of Europe
       9.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
       9.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 10. Asia-Pacific Viral Vector & Plasmid DNA Manufacturing Market By Country

10.1. Asia-Pacific Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific Viral Vector & Plasmid DNA Manufacturing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
         10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         10.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.4. Japan
         10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         10.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.5. India
         10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         10.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.6. Australia
         10.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         10.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.7. South Korea
         10.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         10.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
         10.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         10.8.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 11. Latin America Viral Vector & Plasmid DNA Manufacturing Market By Country

11.1. Latin America Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America Viral Vector & Plasmid DNA Manufacturing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
         11.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         11.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.4. Argentina
         11.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         11.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.5. Rest of Latin America
         11.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         11.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 12. Middle East Viral Vector & Plasmid DNA Manufacturing Market By Country

12.1. Middle East Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East Viral Vector & Plasmid DNA Manufacturing Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Saudi Arabia
         12.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         12.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.4. UAE
         12.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         12.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.5. Rest of Middle East
         12.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         12.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 13. Africa Viral Vector & Plasmid DNA Manufacturing Market By Country

13.1. Africa Viral Vector & Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Africa Viral Vector & Plasmid DNA Manufacturing Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. South Africa
         13.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         13.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
13.4. Egypt
         13.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         13.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
13.5. Rest of Africa
         13.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
         13.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 14. COMPANY PROFILE

14.1. CobraBiologics
         14.1.1. Company Snapshot
         14.1.2. Overview
         14.1.3. Financial Overview
         14.1.4. Product Portfolio
         14.1.5. Key Developments
         14.1.6. Strategies
14.2. Novasep
         14.2.1. Company Snapshot
         14.2.2. Overview
         14.2.3. Financial Overview
         14.2.4. Product Portfolio
         14.2.5. Key Developments
         14.2.6. Strategies
14.3. Spark Therapeutics, Inc.
         14.3.1. Company Snapshot
         14.3.2. Overview
         14.3.3. Financial Overview
         14.3.4. Product Portfolio
         14.3.5. Key Developments
         14.3.6. Strategies
14.4. FUJIFILM Diosynth Ltd
         14.4.1. Company Snapshot
         14.4.2. Overview
         14.4.3. Financial Overview
         14.4.4. Product Portfolio
         14.4.5. Key Developments
         14.4.6. Strategies
14.5. Cell and Gene Therapy Catapult
         14.5.1. Company Snapshot
         14.5.2. Overview
         14.5.3. Financial Overview
         14.5.4. Product Portfolio
         14.5.5. Key Developments
         14.5.6. Strategies
14.6. Kaneka Eurogentec, Inc.
         14.6.1. Company Snapshot
         14.6.2. Overview
         14.6.3. Financial Overview
         14.6.4. Product Portfolio
         14.6.5. Key Developments
         14.6.6. Strategies
14.7. Merck KGaA
         14.7.1. Company Snapshot
         14.7.2. Overview
         14.7.3. Financial Overview
         14.7.4. Product Portfolio
         14.7.5. Key Developments
         14.7.6. Strategies
14.8. Lonza
         14.8.1. Company Snapshot
         14.8.2. Overview
         14.8.3. Financial Overview
         14.8.4. Product Portfolio
         14.8.5. Key Developments
         14.8.6. Strategies
14.9. UniQure N.V.
         14.9.1. Company Snapshot
         14.9.2. Overview
         14.9.3. Financial Overview
         14.9.4. Product Portfolio
         14.9.5. Key Developments
         14.9.6. Strategies
14.10. Others
           14.10.1. Company Snapshot
           14.10.2. Overview
           14.10.3. Financial Overview
           14.10.4. Product Portfolio
           14.10.5. Key Developments
           14.10.6. Strategies

CHAPTER 15. RESEARCH APPROACH

15.1. Research Methodology
         15.1.1. Initial Data Search
         15.1.2. Secondary Research
         15.1.3. Primary Research
15.2. Assumptions and Scope